Evidence map›Paper›PMID 23772351›Full record

ArticleACS macro letters2013

Generating Better Medicines for Cancer.

Stuart S Dunn, James D Byrne, Jillian L Perry, Kai Chen, Joseph M Desimone

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS macro letters, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Stuart S DunnWyss Institute for Biologically Inspired Engineering, School of Engineering and Applied Sciences, Harvard University, Cambridge, Massachusetts 02138, USA.
James D Byrne
Jillian L Perry
Kai Chen
Joseph M Desimone
Harvard University · USNorth Carolina State University · USSegeberger Kliniken · DE

Funding

Translational Nanosystems for Improved Lung Cancer Treatment with Small MoleculesU54CA151652 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DESIMONE, JOSEPH M. · 2010 to 2014
$12.1M
Delivery of Biological Therapeutics: Using Engineered Particles and Novel DeliverDP1OD006432 · OD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DESIMONE, JOSEPH M. · 2009 to 2011
$2.2M
Engineered Organic Particles of Controlled Size, Shape and Surface Chemistry for R01EB009565 · NIBIB · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DESIMONE, JOSEPH M. · 2009 to 2012
$1.3M
NCI NIH HHS U54 CA151652NIBIB NIH HHS R01 EB009565NIH HHS DP1 OD006432
6 · The paper itself

Abstract

The complexity of tumor biology warrants tailored drug delivery for overcoming the major challenges faced by cancer therapies. The versatility of the PRINT

Indexed as

cancerdrug deliverymedicinenanoparticlePRINTsoft lithography

Identifiers

PMID23772351
PMCPMC3680140
OpenAlexW2051084516

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.